Characterization of TGFβ-specific CD4+T cells through the modulation of TGFβ expression in malignant myeloid cells

Rasmus Erik Johansson Mortensen; Morten Orebo Holmström; Mads Hald Andersen

doi:10.1038/s41423-021-00770-0

Characterization of TGFβ-specific CD4⁺T cells through the modulation of TGFβ expression in malignant myeloid cells

Rasmus Erik Johansson Mortensen, Morten Orebo Holmström, Mads Hald Andersen^*

^*Corresponding author af dette arbejde

Center for Cancer Immune Therapy (CCIT), Department of Oncology, Copenhagen University Hospital , Herlev, Denmark.

3 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Cellular and Molecular Immunology
Vol/bind	18
Udgave nummer	11
Sider (fra-til)	2575-2577
Antal sider	3
ISSN	1672-7681
DOI	https://doi.org/10.1038/s41423-021-00770-0
Status	Udgivet - nov. 2021

Adgang til dokumentet

10.1038/s41423-021-00770-0

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{02f925fe389e43a6bd56316b038d0bad,

title = "Characterization of TGFβ-specific CD4+T cells through the modulation of TGFβ expression in malignant myeloid cells",

author = "Mortensen, {Rasmus Erik Johansson} and Holmstr{\"o}m, {Morten Orebo} and Andersen, {Mads Hald}",

note = "Funding Information: This project was supported by Danish Health Authority grant “Empowering Cancer Immunotherapy in Denmark” (grant number 4-1612-236/8), the Copenhagen University Hospital, Herlev, and Gentofte and through a research funding agreement between IO Biotech ApS and the National Center for Cancer Immune Therapy (CCIT-DK). We greatly appreciate the tremendous technical support from Merete Jonassen.",

year = "2021",

month = nov,

doi = "10.1038/s41423-021-00770-0",

language = "English",

volume = "18",

pages = "2575--2577",

journal = "Cellular and Molecular Immunology",

issn = "1672-7681",

publisher = "Nature Publishing Group",

number = "11",

}

TY - JOUR

T1 - Characterization of TGFβ-specific CD4+T cells through the modulation of TGFβ expression in malignant myeloid cells

AU - Mortensen, Rasmus Erik Johansson

AU - Holmström, Morten Orebo

AU - Andersen, Mads Hald

N1 - Funding Information: This project was supported by Danish Health Authority grant “Empowering Cancer Immunotherapy in Denmark” (grant number 4-1612-236/8), the Copenhagen University Hospital, Herlev, and Gentofte and through a research funding agreement between IO Biotech ApS and the National Center for Cancer Immune Therapy (CCIT-DK). We greatly appreciate the tremendous technical support from Merete Jonassen.

PY - 2021/11

Y1 - 2021/11

UR - http://www.scopus.com/inward/record.url?scp=85115194755&partnerID=8YFLogxK

U2 - 10.1038/s41423-021-00770-0

DO - 10.1038/s41423-021-00770-0

M3 - Comment/debate

C2 - 34526675

AN - SCOPUS:85115194755

VL - 18

SP - 2575

EP - 2577

JO - Cellular and Molecular Immunology

JF - Cellular and Molecular Immunology

SN - 1672-7681

IS - 11

ER -